Prescient Design

Prescient Design has joined Genentech's Research and Early Development organization (gRED), applying their cutting-edge technology and machine learning approaches to our drug discovery efforts. We believe that Prescient Design's platform and expertise, combined with our growing internal computational capabilities, will ultimately help us bring better medicines to patients more quickly.